Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 601 of 1,261
  1. US 9796974

    Modified RNAi agents

    Alnylam Pharmaceuticals, Inc. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  2. US 9796673

    L-tartrate salt of pridopidine

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  3. US 9796671

    Aurora kinase inhibitors

    Regents of the University of Minnesota · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  4. US 9796756

    Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA

    Arrowhead Pharmaceuticals, Inc. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  5. US 9796755

    Methods of treating depression and other related diseases

    Northwestern University · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  6. US 9796728

    Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereof

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  7. US 9796718

    6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine

    GILEAD CONNECTICUT, INC. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  8. US 9795661

    TH1/TH2 polarizing vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  9. US 9796976

    Methods and compositions for modulating alpha-1 antitrypsin expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  10. US 9796759

    Ang-(1-7) derivative oligopeptides and methods for using and producing the same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  11. US 9795567

    Immediate release formulations and dosage forms of gamma-hydroxybutyrate

    Jazz Pharmaceuticals, Inc. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  12. US 9795655

    Modified MT-SP1 proteases that inhibit complement activation

    Catalyst Biosciences, Inc. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  13. US 9795662

    Vaccine comprising AMA1 and RON2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  14. US 9796664

    Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  15. WO 2017178577

    APPLICATION MÉDICALE DE RESMINOSTAT CHEZ DES PATIENTS ASIATIQUES

    4SC AG [DE] · Granted Oct 19, 2017 · Expires Oct 14, 2037

    granted
  16. WO 2017179025

    POLYPEPTIDES ÉPITOPIQUES D'ALLERGÈNES DE POLLEN D'AMBROISIE

    ALK-ABELLÓ AS [DK] · Granted Oct 19, 2017 · Expires Oct 14, 2037

    granted
  17. US 9790215

    Pyridazinone compounds and methods for the treatment of cystic fibrosis

    Flatley Discovery Lab, LLC · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  18. US 9789075

    Compositions and methods for treating cardiovascular diseases

    Infirst Healthcare Limited · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  19. US 9790201

    Piperidine and azepine derivatives as prokineticin receptor modulators

    Takeda Pharmaceutical Company Limited · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  20. US 9790273

    Anti-HLA-B*27 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  21. US 9790274

    Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastases

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  22. US 9789096

    Methods and compositions for selective and targeted cancer therapy

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  23. US 9789129

    Stimulation of an immune response by enantiomers of cationic lipids

    PDS Biotechnology Corporation · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  24. US 9789162

    Systemic and local ex vivo gene therapy of the skeleton

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.